Bringing innovative therapies to our patients.
To bring innovative therapies to our patients, the Division of Immunology and Rheumatology conducts clinical trials.
Investigator-initiated and industry-sponsored clinical trials.
Matthew Baker, MD, MS
Dr. Baker is the co-director of the Stanford Multidisciplinary Sarcoidosis Program and an investigator in the Clinical Trials research group in the Division of Immunology and Rheumatology. In addition to caring for patients, he performs clinical trials, epidemiologic studies, and translational laboratory research. His primary focus includes studies of sarcoidosis, IgG4-related disease, and Sjögren’s syndrome. He is particularly interested in identifying novel therapies for patients with these rare diseases.
Lorinda Chung, MD
Dr. Chung leads a team of clinicians and researchers focusing on systemic sclerosis (SSc) patient care and research. In addition to providing exceptional care, the center maintains a detailed clinical database and biorepository of tissue samples that are used in collaborative studies. Dr. Chung’s particular research areas of interest include epidemiologic, outcomes, and translational studies on cutaneous, pulmonary, musculoskeletal, gastrointestinal, and reproductive complications of SSc and related connective tissue diseases.
Tamiko Katsumoto, MD
Dr. Katsumoto is the Director of the Stanford Immune Related Toxicity Working Group for cancer immunotherapies. She is involved in several clinical and translational collaborations to better understand irAE pathogenesis and optimize the management of irAEs. She is also involved in clinical trials testing cellular therapies for the treatment of autoimmune disease. She is passionate about sustainability and is involved in an educational intervention study for health care providers focusing on the merits of plant-rich diets for individual and planetary health.
Mark Genovese, MD, Emeritus
Dr. Genovese was the founder and director of the Clinical Trials research group in the Division of Immunology and Rheumatology and his research was in the areas of clinical trials, outcomes, and biomarkers. His focus included studies of Rheumatoid Arthritis, Psoriatic Arthritis, and Osteoarthritis.
Open Clinical Trials
Patients are carefully matched to each clinical trial, meeting specific entry criteria. Clinical trials are critical to the development of new treatments. Participating in a clinical trial is an opportunity to advance medical research.
Please search below by selecting the PI/Investigator and Condition/Disease.